Stockscreener 앱 받기
0.9058
4.54%
-0.0431
시간 외 거래:
.82
-0.0858
-9.47%
Cytomed Therapeutics Ltd 주식(GDTC)의 최신 뉴스
CytoMed Therapeutics Ltd SEC Filing (Aug 11, 2026) - Stock Titan
CytoMed Therapeutics Ltd (GDTC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CytoMed Therapeutics Ltd (GDTC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
CytoMed Therapeutics Ltd (GDTC) Institutional Confidence - TradingKey
GDTC|CytoMed Therapeutics Ltd|Price:0.880|Chg%:-0.110 - TradingKey
CytoMed Therapeutics Ltd (GDTC) Cash Flow - TradingKey
CytoMed Therapeutics Ltd (GDTC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
CytoMed Therapeutics Ltd (GDTC) Balance Sheet - TradingKey
CytoMed Therapeutics Ltd (GDTC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
CytoMed Therapeutics Ltd (GDTC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CytoMed Therapeutics Ltd (GDTC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CytoMed Therapeutics Ltd (GDTC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
GDTC|CytoMed Therapeutics Ltd|Price:0.990|Chg%:+0.140 - TradingKey
CytoMed Therapeutics Ltd (GDTC) Valuation: PE, PB & Fair Value Analysis - TradingKey
CytoMed Therapeutics Ltd (GDTC) Income Statement - TradingKey
Form 13D/A CytoMed Therapeutics Ltd For: 24 July By Investing.com - Investing.com South Africa
CytoMed Therapeutics (GDTC) director adds 200,000 shares in July buys - Stock Titan
Form 4 CytoMed Therapeutics Ltd For: 24 July By Investing.com - Investing.com South Africa
CytoMed Therapeutics (GDTC) insider discloses two ordinary share dispositions - Stock Titan
CytoMed Therapeutics' US$1.7m Market Cap Fall Books Insider Losses - simplywall.st
CytoMed Therapeutics Ltd – An Emerging Star in Singapore’s Cancer Biotechnology Sector - FinancialContent
CytoMed Therapeutics(GDTC) Stock Options Chain | Quotes & News - Moomoo
CytoMed Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting) - Moomoo
CytoMed Therapeutics (GDTC) Stock Forecast & Analyst Ratings - Moomoo
CytoMed Therapeutics Ltd (NASDAQ: GDTC) – A Rising Star in Singapore’s Cancer Biotechnology Sector - FinancialContent
GDTCCytoMed Therapeutics Ltd Options - Finviz
CytoMed, a Singapore Biotech, RevolutionizesCancer Treatment Using Donor Immune Cells - openPR.com
CytoMed Chairman Boosts Personal Stake and Funds R&D Expansion at LongevityBank - The Globe and Mail
Form 6K CytoMed Therapeutics Ltd For: 23 June - Investing.com UK
Form 6K CytoMed Therapeutics Ltd For: 23 June By Investing.com - Investing.com Australia
CytoMed Therapeutics (NASDAQ: GDTC) chair ups exposure and funds LongevityBank R&D - Stock Titan
CytoMed Therapeutics (NASDAQ: GDTC) director buys 112,000 shares in open market - Stock Titan
CytoMed Therapeutics (NASDAQ: GDTC) shareholders approve all AGM proposals - Stock Titan
CytoMed Therapeutics (GDTC) Dips 2.48% as Key Support at $1.08 Comes into FocusDouble Top - newsline.com
CytoMed Therapeutics (NASDAQ: GDTC) director discloses holding 4,000 Ordinary Shares - Stock Titan
CytoMed Therapeutics LtdA Rising Star in Singapore's Cancer Biotechnology Sector - openPR.com
CytoMed Therapeutics Limited is accelerating its international expansion - openPR.com
CytoMed Therapeutics (NASDAQ: GDTC) director reports 2,469 ordinary shares on Form 3 - Stock Titan
CytoMed Therapeutics (NASDAQ: GDTC) director files initial Form 3 ownership - Stock Titan
CytoMed Therapeutics (NASDAQ: GDTC) director Choo Chee Kong details direct and indirect share ownership - Stock Titan
CytoMed Therapeutics (NASDAQ: GDTC) CFO reports holding 25,781 ordinary shares - Stock Titan
CytoMed Therapeutics (GDTC) chair adds 112,000 shares in private purchase - Stock Titan
[144] CytoMed Therapeutics Ltd SEC Filing - Stock Titan
1.80%
1.77%
자본화:
|
볼륨(24시간):